rxstat › Shortages › Collagenase

Collagenase shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 9, 2026

Collagenase products have been discontinued in Canada. See the reports below for which products and when.
Products affected
0 / 1
Reports on file
2

Reports by product

Discontinued
SANTYL
250UNIT · OINTMENT · SMITH & NEPHEW INC
DIN 02063670
Resolved
SANTYL
250UNIT · OINTMENT · SMITH & NEPHEW INC
DIN 02063670 · ended Jan 28, 2026 · Disruption of the manufacture of the drug.

What's happening

One or more Collagenase products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Collagenase is classified under “ENZYMES” (ATC D03BA).

Recent changes

Common questions

When will Collagenase be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Collagenase in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.